Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0001610717-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 9, 2026 |
| Document Date | Jan 7, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
225,000
Total Value
$10,427,308.41
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jan 7, 2026 | Exercise/Conversion | 51,406 | $42.45 | $2,182,184.70 | 192,459 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 7, 2026 | Exercise/Conversion | 23,594 | $29.80 | $703,101.20 | 216,053 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 7, 2026 | Sale | 53,096 | $100.02 | $5,310,470.77 | 162,957 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 7, 2026 | Sale | 20,204 | $101.79 | $2,056,621.73 | 142,753 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 7, 2026 | Sale | 1,700 | $102.90 | $174,930.00 | 141,053 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jan 7, 2026 | Exercise/Conversion | 51,406 | $0.00 | $0.00 | 1,094 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jan 7, 2026 | Exercise/Conversion | 23,594 | $0.00 | $0.00 | 119,906 | Direct | โ | View Details |